multiple dosage study [Regulatives / Guidelines]

posted by VStus – Poland, 2016-08-24 23:37 (2795 d 07:18 ago) – Posting: # 16572
Views: 5,675

Hi Mahesh,

❝ “lack of accumulation" (by SPC, PAR or literature) and the provide partial AUC for both fasting and fed two way study as supportive data.


On my opinion, it's clearly stated that SPC, PAR or literature is not sufficient as both Test and Reference product's data are required:

6.1.1.2. Multiple dose studies
A multiple dose study is needed unless a single dose study has been performed with the highest strength which has demonstrated that the mean AUC(0-tau) after the first dose covers more than 90% of mean AUC(0-∞) for both test and reference, and consequently a low extent of accumulation is expected.


Best regards,
VStus

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,654 registered users;
124 visitors (0 registered, 124 guests [including 6 identified bots]).
Forum time: 06:55 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5